Skip to main content
Clinical Trials/IRCT2012101511125N1
IRCT2012101511125N1
Completed
Phase 2

Comparison of the efficacy and extend of ocular surface toxicity between a preservative- free methylprednisolone topical preparation and preserved prednisolone eye drop in the treatment of acute anterior uveitis

Vice chancellor for research of Noor Ophthalmic research Center (NORC)0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
acute anterior uveitis.
Sponsor
Vice chancellor for research of Noor Ophthalmic research Center (NORC)
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research of Noor Ophthalmic research Center (NORC)

Eligibility Criteria

Inclusion Criteria

  • Eligibility criteria were:
  • 1\- age 16 years or older; 2\- attack duration less than one week period; 3\- no high intraocular pressure at presentation; 4\-negative clues for infectious (e.g. corneal scars, iris atrophy) or granulomatous inflammation (e.g. granulomatous keratic precipitate or iris nodule).
  • The following exclusion criteria would be used:
  • 1\-eyes with hypopyon or florid fibrin formation; 2\-prior unsuccessful topical treatment; 3\- known cases of Behcet disease; 4\-any slit\-lamp evidence of significant blepharitis or meibomian gland dysfunction; 5\-recent use of contact lenses.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials